Kim Tieu
Concepts (185)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Parkinson Disease | 13 | 2001 | 67 |
Why?
|
Neuroprotective Agents | 5 | 2002 | 60 |
Why?
|
Mitochondria | 6 | 2003 | 100 |
Why?
|
Astrocytes | 6 | 2001 | 62 |
Why?
|
Parkinsonian Disorders | 7 | 2002 | 19 |
Why?
|
Protein Kinases | 3 | 2007 | 64 |
Why?
|
Dopamine | 6 | 2001 | 62 |
Why?
|
Substantia Nigra | 6 | 2001 | 30 |
Why?
|
Neurodegenerative Diseases | 2 | 2005 | 30 |
Why?
|
Quinazolinones | 1 | 2010 | 2 |
Why?
|
Organic Cation Transport Proteins | 1 | 2009 | 4 |
Why?
|
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 9 | 2002 | 11 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 1999 | 82 |
Why?
|
Neurons | 10 | 2001 | 195 |
Why?
|
3-Hydroxyacyl CoA Dehydrogenases | 1 | 2004 | 3 |
Why?
|
Oxidopamine | 3 | 1999 | 21 |
Why?
|
Cell Respiration | 2 | 2003 | 11 |
Why?
|
Reactive Oxygen Species | 5 | 2003 | 112 |
Why?
|
3-Hydroxybutyric Acid | 1 | 2003 | 4 |
Why?
|
Nitric Oxide | 2 | 2003 | 85 |
Why?
|
Antiparkinson Agents | 1 | 2004 | 23 |
Why?
|
Mice | 18 | 2001 | 623 |
Why?
|
Mutation | 1 | 2010 | 340 |
Why?
|
Animals | 20 | 2001 | 1031 |
Why?
|
Mice, Inbred C57BL | 9 | 2002 | 318 |
Why?
|
Cell Survival | 2 | 1999 | 229 |
Why?
|
Models, Biological | 4 | 2005 | 410 |
Why?
|
Dopamine Agents | 4 | 2002 | 19 |
Why?
|
Staurosporine | 1 | 1999 | 24 |
Why?
|
Microglia | 5 | 2001 | 29 |
Why?
|
Tretinoin | 1 | 1999 | 48 |
Why?
|
Ubiquitin-Protein Ligases | 2 | 2009 | 41 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 1999 | 71 |
Why?
|
Mesencephalon | 3 | 2004 | 22 |
Why?
|
Glutathione | 2 | 2009 | 65 |
Why?
|
RNA, Small Interfering | 2 | 2007 | 116 |
Why?
|
Nerve Degeneration | 2 | 2003 | 43 |
Why?
|
Electron Transport Complex I | 3 | 2002 | 8 |
Why?
|
MPTP Poisoning | 3 | 2003 | 6 |
Why?
|
Isoenzymes | 3 | 2003 | 144 |
Why?
|
Nerve Tissue Proteins | 3 | 2002 | 128 |
Why?
|
Hydrogen Peroxide | 3 | 2003 | 75 |
Why?
|
Humans | 19 | 1999 | 1856 |
Why?
|
Electron Transport | 2 | 2003 | 13 |
Why?
|
Cell Differentiation | 1 | 1999 | 262 |
Why?
|
Oxidants | 2 | 2003 | 47 |
Why?
|
Oxidative Stress | 4 | 2003 | 119 |
Why?
|
Genetic Techniques | 2 | 2005 | 27 |
Why?
|
Corpus Striatum | 3 | 2002 | 48 |
Why?
|
Disease Models, Animal | 6 | 2002 | 349 |
Why?
|
Mitochondrial Proteins | 2 | 2004 | 26 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 2 | 2003 | 66 |
Why?
|
Neurotransmitter Agents | 1 | 2010 | 30 |
Why?
|
Acupuncture Analgesia | 1 | 2010 | 5 |
Why?
|
Receptors, Purinergic P1 | 1 | 2010 | 19 |
Why?
|
Dynamins | 1 | 2010 | 6 |
Why?
|
Afferent Pathways | 1 | 2010 | 24 |
Why?
|
Steroids | 1 | 2010 | 38 |
Why?
|
Membrane Transport Proteins | 1 | 2010 | 43 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2009 | 18 |
Why?
|
Autophagy | 1 | 2009 | 7 |
Why?
|
Time Factors | 3 | 2001 | 896 |
Why?
|
Ubiquitin | 1 | 2010 | 41 |
Why?
|
Neuroblastoma | 2 | 1999 | 36 |
Why?
|
Adenosine | 1 | 2010 | 57 |
Why?
|
Brain | 4 | 2002 | 305 |
Why?
|
Membrane Proteins | 3 | 2003 | 233 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2010 | 45 |
Why?
|
Glutamic Acid | 1 | 2009 | 66 |
Why?
|
Tumor Cells, Cultured | 2 | 1999 | 233 |
Why?
|
NADH, NADPH Oxidoreductases | 2 | 2002 | 14 |
Why?
|
Pain | 1 | 2010 | 191 |
Why?
|
RNA Interference | 1 | 2007 | 75 |
Why?
|
NADPH Oxidase | 2 | 2002 | 21 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2005 | 20 |
Why?
|
bcl-2-Associated X Protein | 1 | 2005 | 40 |
Why?
|
Peroxidase | 1 | 2005 | 27 |
Why?
|
Tyrosine 3-Monooxygenase | 2 | 2002 | 30 |
Why?
|
Mice, Transgenic | 2 | 2004 | 209 |
Why?
|
Nitric Oxide Synthase | 2 | 2002 | 44 |
Why?
|
Tyrosine | 2 | 2002 | 71 |
Why?
|
Uncoupling Agents | 1 | 2004 | 12 |
Why?
|
Mice, Knockout | 5 | 2002 | 265 |
Why?
|
Adenosine Triphosphate | 2 | 2003 | 121 |
Why?
|
Oxidative Phosphorylation | 1 | 2004 | 19 |
Why?
|
Oxygen | 2 | 2003 | 179 |
Why?
|
Hydroxybutyrate Dehydrogenase | 1 | 2003 | 3 |
Why?
|
Neurotoxins | 2 | 1999 | 33 |
Why?
|
Rats | 2 | 2004 | 530 |
Why?
|
NAD | 1 | 2003 | 41 |
Why?
|
Free Radicals | 1 | 2003 | 25 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 4 | 2003 | 243 |
Why?
|
Minocycline | 1 | 2002 | 13 |
Why?
|
Motor Activity | 1 | 2003 | 104 |
Why?
|
RNA, Messenger | 3 | 2001 | 394 |
Why?
|
Male | 6 | 2002 | 1553 |
Why?
|
Neuroglia | 1 | 2002 | 49 |
Why?
|
Culture Media, Conditioned | 1 | 2001 | 45 |
Why?
|
Coculture Techniques | 1 | 2001 | 59 |
Why?
|
Benzylamines | 1 | 1999 | 9 |
Why?
|
Cell Separation | 1 | 2001 | 110 |
Why?
|
Gamma Rays | 1 | 1999 | 38 |
Why?
|
Fluorouracil | 1 | 1999 | 49 |
Why?
|
Blotting, Western | 1 | 2001 | 275 |
Why?
|
Cell Death | 2 | 2003 | 94 |
Why?
|
Cell Line | 2 | 2007 | 375 |
Why?
|
Immunohistochemistry | 2 | 2003 | 355 |
Why?
|
Cyclooxygenase 2 | 2 | 2003 | 77 |
Why?
|
Pregnenolone | 1 | 2010 | 3 |
Why?
|
Microdissection | 1 | 2010 | 7 |
Why?
|
Dehydroepiandrosterone Sulfate | 1 | 2010 | 8 |
Why?
|
Sciatica | 1 | 2010 | 6 |
Why?
|
Dehydroepiandrosterone | 1 | 2010 | 16 |
Why?
|
Nucleotidases | 1 | 2010 | 11 |
Why?
|
Biological Transport, Active | 1 | 2010 | 51 |
Why?
|
Adrenal Glands | 1 | 2010 | 35 |
Why?
|
Carbonyl Cyanide m-Chlorophenyl Hydrazone | 1 | 2009 | 8 |
Why?
|
Ionophores | 1 | 2009 | 15 |
Why?
|
Pain Management | 1 | 2010 | 32 |
Why?
|
Brain Chemistry | 1 | 2010 | 60 |
Why?
|
Statistics, Nonparametric | 1 | 2010 | 141 |
Why?
|
Xenopus laevis | 1 | 2010 | 49 |
Why?
|
Oocytes | 1 | 2010 | 45 |
Why?
|
Microtubules | 1 | 2009 | 38 |
Why?
|
Protein Transport | 1 | 2009 | 101 |
Why?
|
Disease | 1 | 2009 | 27 |
Why?
|
Apoptosis | 2 | 2004 | 265 |
Why?
|
Female | 2 | 2002 | 1643 |
Why?
|
Homeostasis | 1 | 2009 | 99 |
Why?
|
Analysis of Variance | 1 | 2010 | 339 |
Why?
|
TATA Box | 1 | 2007 | 14 |
Why?
|
Crosses, Genetic | 1 | 2007 | 47 |
Why?
|
RNA, Small Nuclear | 1 | 2007 | 10 |
Why?
|
Disease Progression | 1 | 2009 | 244 |
Why?
|
Protein Binding | 1 | 2009 | 256 |
Why?
|
Cardiolipins | 1 | 2005 | 7 |
Why?
|
Submitochondrial Particles | 1 | 2005 | 11 |
Why?
|
Species Specificity | 1 | 2007 | 186 |
Why?
|
DNA, Complementary | 1 | 2007 | 139 |
Why?
|
Hypochlorous Acid | 1 | 2005 | 5 |
Why?
|
Subcellular Fractions | 1 | 2005 | 67 |
Why?
|
Ascorbic Acid | 1 | 2005 | 37 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2005 | 121 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2005 | 65 |
Why?
|
Enzyme Induction | 1 | 2005 | 64 |
Why?
|
Amyotrophic Lateral Sclerosis | 1 | 2005 | 25 |
Why?
|
Cytochromes c | 1 | 2005 | 29 |
Why?
|
Mitochondrial Diseases | 1 | 2004 | 6 |
Why?
|
Microscopy, Confocal | 1 | 2005 | 105 |
Why?
|
Microscopy, Fluorescence | 1 | 2005 | 137 |
Why?
|
Huntington Disease | 1 | 2005 | 30 |
Why?
|
Phenotype | 1 | 2007 | 303 |
Why?
|
Promoter Regions, Genetic | 1 | 2007 | 188 |
Why?
|
Thiazines | 1 | 2003 | 8 |
Why?
|
Glial Cell Line-Derived Neurotrophic Factor | 1 | 2003 | 6 |
Why?
|
Adrenergic Agents | 1 | 2003 | 5 |
Why?
|
Transfection | 1 | 2007 | 237 |
Why?
|
Superoxides | 1 | 2003 | 36 |
Why?
|
Kidney | 1 | 2007 | 223 |
Why?
|
1-Methyl-4-phenylpyridinium | 1 | 2002 | 2 |
Why?
|
Synucleins | 1 | 2002 | 4 |
Why?
|
Biogenic Monoamines | 1 | 2002 | 2 |
Why?
|
alpha-Synuclein | 1 | 2002 | 9 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2003 | 45 |
Why?
|
Catalysis | 1 | 2003 | 40 |
Why?
|
Cyclooxygenase Inhibitors | 1 | 2003 | 47 |
Why?
|
Thiazoles | 1 | 2003 | 50 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2003 | 48 |
Why?
|
Drug Resistance | 1 | 2002 | 83 |
Why?
|
In Situ Hybridization | 1 | 2003 | 135 |
Why?
|
Nerve Growth Factors | 1 | 2003 | 43 |
Why?
|
Anti-Inflammatory Agents | 1 | 2003 | 80 |
Why?
|
Nitric Oxide Synthase Type II | 1 | 2002 | 39 |
Why?
|
DNA Primers | 1 | 2003 | 208 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2003 | 68 |
Why?
|
Enzyme Activation | 1 | 2003 | 177 |
Why?
|
Gene Expression Regulation | 1 | 2007 | 277 |
Why?
|
Interleukin-1 | 1 | 2002 | 109 |
Why?
|
Chemokines | 1 | 2001 | 48 |
Why?
|
Up-Regulation | 1 | 2002 | 183 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2002 | 431 |
Why?
|
Base Sequence | 1 | 2003 | 371 |
Why?
|
Anti-Bacterial Agents | 1 | 2002 | 195 |
Why?
|
Cytokines | 1 | 2001 | 207 |
Why?
|
Cells, Cultured | 1 | 2002 | 447 |
Why?
|
